ATE542903T1 - Luciferase-biosensoren für camp - Google Patents

Luciferase-biosensoren für camp

Info

Publication number
ATE542903T1
ATE542903T1 AT09750966T AT09750966T ATE542903T1 AT E542903 T1 ATE542903 T1 AT E542903T1 AT 09750966 T AT09750966 T AT 09750966T AT 09750966 T AT09750966 T AT 09750966T AT E542903 T1 ATE542903 T1 AT E542903T1
Authority
AT
Austria
Prior art keywords
camp
luciferase biosensors
biosensors
luciferase
luciferase protein
Prior art date
Application number
AT09750966T
Other languages
English (en)
Inventor
Lance Encell
Kris Zimmerman
Paul Otto
Gediminas Vidugiris
Pete Stecha
Brock Binkowski
Monika Wood
Keith Wood
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Application granted granted Critical
Publication of ATE542903T1 publication Critical patent/ATE542903T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5735Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y113/00Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90241Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT09750966T 2008-05-19 2009-05-19 Luciferase-biosensoren für camp ATE542903T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5437408P 2008-05-19 2008-05-19
US11998308P 2008-12-04 2008-12-04
PCT/US2009/003132 WO2009142735A2 (en) 2008-05-19 2009-05-19 LUCIFERASE BIOSENSORS FOR cAMP

Publications (1)

Publication Number Publication Date
ATE542903T1 true ATE542903T1 (de) 2012-02-15

Family

ID=41202867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09750966T ATE542903T1 (de) 2008-05-19 2009-05-19 Luciferase-biosensoren für camp

Country Status (5)

Country Link
US (2) US9045730B2 (de)
EP (1) EP2281046B1 (de)
JP (2) JP6110591B2 (de)
AT (1) ATE542903T1 (de)
WO (1) WO2009142735A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007508014A (ja) 2003-10-10 2007-04-05 プロメガ コーポレイション ルシフェラーゼバイオセンサー
WO2007120522A2 (en) 2006-04-03 2007-10-25 Promega Corporation Permuted and nonpermuted luciferase biosensors
US9045730B2 (en) 2008-05-19 2015-06-02 Promega Corporation Luciferase biosensors for cAMP
PT2990478T (pt) * 2009-05-01 2017-05-08 Promega Corp Luciferases de oplophorus sintéticas com débito luminoso aumentado
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
US8735559B2 (en) 2010-05-11 2014-05-27 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP2635595B1 (de) 2010-11-02 2019-01-09 Promega Corporation Luciferasen aus oplophorus, neue coelenterazinsubstrate und verwendungsverfahren
PL2635583T3 (pl) 2010-11-02 2015-11-30 Promega Corp Pochodne koelenterazyny i metody ich wykorzystania
AU2011335901B2 (en) 2010-12-03 2016-12-15 Gene Stream Pty Ltd Improved light-emitting molecules
US9547017B2 (en) 2012-03-15 2017-01-17 Montana Molecular Llc Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways
JP2015000021A (ja) * 2013-06-14 2015-01-05 浜松ホトニクス株式会社 細胞内cAMP濃度を制御する方法
JP6484987B2 (ja) 2013-10-21 2019-03-20 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
WO2015066706A2 (en) 2013-11-04 2015-05-07 Montana Molecular Llc GENETICALLY ENCODED FLUORESCENT SENSORS FOR DETECTING LIGAND BIAS AND INTRACELLULAR SIGNALING THROUGH cAMP PATHWAYS
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
WO2015116806A1 (en) 2014-01-29 2015-08-06 Promega Corporation Pro-substrates for live cell applications
JP6265020B2 (ja) * 2014-04-16 2018-01-24 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
EP3510035B1 (de) 2016-09-09 2021-04-07 Promega Corporation Doppelt geschützte pro-coelenterazin-substrate
JP7211596B2 (ja) * 2018-09-05 2023-01-24 ヤマサ醤油株式会社 Tsh受容体に対する自己抗体活性の測定方法及びキット
WO2023215432A1 (en) 2022-05-04 2023-11-09 Promega Corporation Circularly permuted dehalogenase variants
WO2023215452A2 (en) 2022-05-04 2023-11-09 Promega Corporation Split modified dehalogenase variants

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO864301L (no) * 1986-10-28 1988-04-29 Tore Jahnsen Dna-prober for human regulatorisk enhet av camp-avhengige proteinkinaser.
AU4809290A (en) * 1988-11-18 1990-06-12 General Hospital Corporation, The A camp-responsive transcriptional enhancer binding protein
GB8916806D0 (en) 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
US5683888A (en) * 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
FR2682122B1 (fr) 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
JPH08510387A (ja) 1994-01-03 1996-11-05 プロメガ・コーポレイシヨン 突然変異体ルシフェラーゼ
US6294330B1 (en) * 1997-01-31 2001-09-25 Odyssey Pharmaceuticals Inc. Protein fragment complementation assays for the detection of biological or drug interactions
CA2196496A1 (en) * 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US6037137A (en) 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
US7312302B2 (en) 1997-02-20 2007-12-25 Oncolmmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
WO1999014336A2 (en) * 1997-09-19 1999-03-25 Promega Corporation Thermostable luciferases and methods of production
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
US6855515B1 (en) 1998-04-22 2005-02-15 Merck & Co., Inc. Autoantigenic fragments, methods and assays
GB9819666D0 (en) 1998-09-09 1998-11-04 Univ Aberdeen Biosensor
US20020192719A1 (en) * 1998-09-30 2002-12-19 Caliper Technologies Corp. Homogeneous assay methods
US6987004B1 (en) 1998-10-23 2006-01-17 Massachusetts Institute Of Technology Genes integrating signal transduction pathways
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
US6670144B1 (en) * 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
JP3059435B1 (ja) * 1999-03-18 2000-07-04 扶桑薬品工業株式会社 cAMPおよびアデニル酸シクラ―ゼの酵素的蛍光定量アッセイ
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6808874B2 (en) * 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
US6890745B1 (en) 2000-07-19 2005-05-10 Chemicon International, Inc. Protease specific cleavable luciferases and methods of use thereof
US7166447B2 (en) * 2000-07-26 2007-01-23 Japan Science And Technology Corporation Probe for analyzing protein—protein interaction and method of analyzing protein—protein interactions with the use of the same
US6541196B2 (en) * 2000-07-26 2003-04-01 Jackson State University Method for cAMP production
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
US7083911B2 (en) * 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
US20030053995A1 (en) 2001-06-15 2003-03-20 Mien-Chie Hung Methods and compositions for inhibiting EGF receptor activity
US7422862B2 (en) 2001-11-28 2008-09-09 The Burnham Institute Methods for identifying modulators of apoptosis
US7927871B2 (en) 2002-01-29 2011-04-19 Oncoimmunin, Inc. Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
WO2003066883A2 (en) 2002-02-08 2003-08-14 The Regents Of The University Of California A transcription amplification system for molecular imaging
US6730492B2 (en) * 2002-03-09 2004-05-04 Merrimack Pharmaceuticals, Inc. Cell-based screening methods
US20030170850A1 (en) * 2002-03-09 2003-09-11 Cardone Michael H. Cell-based screening methods
JP5155515B2 (ja) * 2002-09-06 2013-03-06 プロメガ コーポレイション トランスフェラーゼ酵素活性を検出する方法
GB0221915D0 (en) 2002-09-20 2002-10-30 Skeland Stein O D Assay
WO2004038039A2 (en) 2002-10-21 2004-05-06 The Regents Of The University Of California Optical imagiong of renilla luciferase reporter gene expression in living organisms
AU2003287635A1 (en) 2002-11-08 2004-06-03 Sanjiv Sam Gambhir Imaging protein-protein interactions in living subjects
EP2325329B1 (de) * 2002-12-23 2014-02-12 Promega Corporation Verbesserte Luciferase-Assays
US7524674B2 (en) 2003-03-07 2009-04-28 Stanford University Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7442518B2 (en) 2003-08-06 2008-10-28 Washington University Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
US7488583B2 (en) * 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
JP2007508014A (ja) 2003-10-10 2007-04-05 プロメガ コーポレイション ルシフェラーゼバイオセンサー
EP1536020A1 (de) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Mittel und Verfahren zur optischen Bestimmung von cAMP in vitro und in vivo
US20060110364A1 (en) 2004-08-20 2006-05-25 Ludwig Institute For Cancer Research Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors
EP1791972A4 (de) 2004-08-23 2009-12-02 Univ Johns Hopkins cAMP-REPORTER
US20060048592A1 (en) * 2004-09-09 2006-03-09 Ung Tom T Damping nut for screw-driven mechanism
CN101283090A (zh) * 2005-08-19 2008-10-08 联邦科学及工业研究组织 菌蚋荧光素酶
WO2007120522A2 (en) 2006-04-03 2007-10-25 Promega Corporation Permuted and nonpermuted luciferase biosensors
CA2663047A1 (en) 2006-09-06 2008-03-13 Phase Bioscience, Inc. Therapeutic elastin-like polypeptide (elp) fusion proteins
US7812002B2 (en) 2007-03-21 2010-10-12 Quark Pharmaceuticals, Inc. Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
US8658777B2 (en) 2007-05-09 2014-02-25 The University Of Tokyo Activated protease indicator
WO2009049892A1 (en) 2007-10-17 2009-04-23 European Molecular Biology Laboratory (Embl) Polypeptides comprising an annexin core domain, compositions, methods and use thereof
US20090253131A1 (en) * 2007-11-05 2009-10-08 Promega Corporation Hybrid fusion reporter and uses thereof
US20090286299A1 (en) * 2008-05-15 2009-11-19 Mostafa Ronaghi Engineered luciferases
US9045730B2 (en) 2008-05-19 2015-06-02 Promega Corporation Luciferase biosensors for cAMP
US8735559B2 (en) 2010-05-11 2014-05-27 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
JP5501862B2 (ja) 2010-05-24 2014-05-28 株式会社サンユー 金属被膜見本キット
EP2635595B1 (de) 2010-11-02 2019-01-09 Promega Corporation Luciferasen aus oplophorus, neue coelenterazinsubstrate und verwendungsverfahren
EP3467119B1 (de) 2011-11-11 2022-02-23 Promega Corporation Mutante prothease-biosensoren mit verbesserten erkennungseigenschaften

Also Published As

Publication number Publication date
WO2009142735A3 (en) 2010-01-14
JP2015091253A (ja) 2015-05-14
JP6275635B2 (ja) 2018-02-07
US20090305280A1 (en) 2009-12-10
EP2281046B1 (de) 2012-01-25
WO2009142735A2 (en) 2009-11-26
US9045730B2 (en) 2015-06-02
US9879306B2 (en) 2018-01-30
EP2281046A2 (de) 2011-02-09
JP6110591B2 (ja) 2017-04-05
JP2011520466A (ja) 2011-07-21
US20150299765A1 (en) 2015-10-22

Similar Documents

Publication Publication Date Title
ATE542903T1 (de) Luciferase-biosensoren für camp
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
DE112007001307A5 (de) Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
BRPI0822775A2 (pt) Método de obtenção de uma proteína heteróloga, purificada, biologicamente ativa.
BRPI0918648A2 (pt) anticorpos multiespecíficos
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
BRPI0921243A2 (pt) fornecimento de história recente com resultados de pesquisa.
BRPI0919186A2 (pt) aparelhos de barbear ou depilar e cartuchos.
TR201901930T4 (tr) Topraktaki mikrobiyal aktivitenin geliştirilmesine yönelik bir yöntem.
MA32712B1 (fr) Anticorps anti-vegf/anti-ang-2 bispecifique
DK2534240T3 (da) Gærmikroorganismer med reduceret biprodukt-akkumulering til forbedret fremstilling af brændstoffer, kemikalier og aminosyrer
ES2386734T8 (es) Ácidos fenoxiacéticos como activadores de PPAR-delta.
EA201171325A1 (ru) Нуклеиновые кислоты, связывающиеся с гепсидином
EA201000327A1 (ru) Белок
DK2002016T3 (da) Fremgangsmåde til bestemmelse af kopital
MX2011006301A (es) Produccion de alcoholes de cadena ramificada por medio de microorganismos fotosinteticos.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
TR201903645T4 (tr) Bir termize taze peynirin imalatına yönelik yöntem ve elde edilen peynir.
DK2179035T3 (da) Modificeret bakteriofag omfattende et alfa/beta-sasp-(small acid-soluble spore protein)-gen
BRPI0914098A2 (pt) biosensor
DOP2009000088A (es) Pirazoles sustituidos que presentan actividad anticancerígena
BR112014014279A2 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit
BRPI0822347A2 (pt) método de produção de proteínas ou peptídeos heterólogos.
DK2004149T3 (da) Farmaceutiske sammensætninger indeholdende leflunomid